Status:
UNKNOWN
Breakthrough Improvement Collaborative for ColoRectal Cancer (BIC4CRC)
Lead Sponsor:
KU Leuven
Collaborating Sponsors:
Kom Op Tegen Kanker
Conditions:
Colorectal Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Colorectal cancer is the most common cancer in Europe and the third worldwide. Approximately 1 in 20 men and 1 in 35 women will develop colorectal cancer at some moment in their life. In Flanders, in ...
Eligibility Criteria
Inclusion
- Minimum age of 18 years
- Elective admission for colorectal cancer surgery
Exclusion
- Emergency (not planned) admission for colorectal cancer surgery
- Patients diagnosed with severe dementia or severe concomitant disease that may affect very short term outcome and hence influence deviations from standard acute care
Key Trial Info
Start Date :
March 30 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
950 Patients enrolled
Trial Details
Trial ID
NCT03320317
Start Date
March 30 2018
End Date
December 1 2025
Last Update
February 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
KU Leuven
Leuven, Vlaams-brabant, Belgium, 3000